
Faheema Hasan/X
Feb 11, 2025, 08:11
Faheema Hasan: History to management of primary and secondary HLH
Faheema Hasan, Assistant Professor and Hemato-Oncology at UIMS, shared an article by Jan-Inge Henter, et al. on X:
“Beautiful review of HLH on NEJM from history to management of primary and secondary HLH In the revised HLH 2024 criteria, natural killer cell activity is removed as a criterion, a huge relief and 5/7 criteria to be met for diagnosis.”
Hemophagocytic Lymphohistiocytosis.
Authors: Jan-Inge Henter
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 26, 2025, 19:51
Mar 26, 2025, 18:12
Mar 26, 2025, 18:03